I f malignant cells from solid or blood cancers enter the central nervous system (CNS) and grow there, the treatment options and clinical outlook deteriorate rapidly. In a type of leukaemia called acute lymphoblastic leukaemia (ALL), invasion of the CNS commonly occurs. To try to limit this, people with the condition often receive radia tion or chemotherapy that targets the CNS. If moreeffective and lesstoxic approaches became available to prevent disease spread to the CNS, this might benefit many people with ALL. On page 55, Yao et al.
1 report a hitherto unknown route that ALL cells use to enter the CNS, and suggest a possible therapeutic approach that is worth investigating.
When leukaemia spreads into the CNS, this process, termed metastasis, is mainly limited to the region known as the subarachnoid space, which contains cerebrospinal fluid that bathes the brain and spinal cord. The subarachnoid space is surrounded by membranes called the dura mater, the pia mater and the arachnoid, which are collectively called the meninges and are also colonized by cancer cells (Fig. 1 ). Yao and colleagues used mouse models of ALL to investigate how human leukaemia cells spread into the CNS. They focused on the enzyme PI3K, which is a key regulator of signalling pathways needed for growth, survival and invasion by cancer cells.
The authors studied three different mouse models of ALL, and gave animals a molecule called GS649443 that inhibits a version of PI3K called PI3Kδ. Animals that received the drug had reduced signs of cancer invasion of the CNS compared with those that did not receive it. The authors studied bonemarrow sites that are commonly rich in leukaemic cells, and found no evidence that the drug was affecting the growth or motility of leukaemic cells or cancer progression at sites outside the CNS. This result suggests that PI3K inhibition specifically affects the ability of leukaemic cells to enter the CNS -which is surprising, because the blood-brain barrier usually poses a formidable obstacle that restricts the ability of molecules or cells to exit blood vessels and enter the brain or the cerebrospinal fluid. Cancer cells that reach the CNS are likely to be beyond the reach of drugs present in the body's bloodstream. Yao and colleagues analysed gene expres sion in cancer cells to identify genes whose expression decreased as a result of PI3K inhibition. This pointed them towards the gene that encodes a receptor protein called α6 integrin. This receptor can bind a protein called laminin, which is a key component of the extracellular material that surrounds large blood vessels. Laminin is also a component of the meninges 2 and is present in a CNS struc ture called the choroid plexus, which is where
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A cancer shortcut to the nervous system
Certain cancers are prone to invade the nervous system, which leads to poorer prognosis. A study of leukaemia in mice reveals an unexpectedly direct invasion route from the bone marrow to the central nervous system. See Article p.55
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Origin of the blues
Some diamonds are a beautiful blue colour, because they contain trace quantities of boron. But blue diamonds are formed in Earth's mantle, whereas boron is concentrated in the crust. So where did these diamonds get their boron from? On page 84, Smith et al. provide the answer to this geochemical conundrum (E. M. Smith et al. Nature 560, 84-87; 2018) .
The authors analysed minerals trapped in 46 blue diamonds, and from this worked out that the gemstones must have formed in the lower mantle. Their analysis also suggests that the material from which the diamonds formed contained water and came from the oceanic lithosphere (tectonic plates beneath the sea), a rich source of boron.
The findings mean that blue diamonds are some of the deepest ever found. Moreover, they reveal a geochemical pathway that extends from the oceanic lithosphere at Earth's surface to the lower mantle, and a potential route for the ultra-deep cycling of water in our planet. Andrew Mitchinson 
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